> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection for In Vivo Radiopharmaceuticals
- URL: https://www.fdaweb.com/info-collection-for-in-vivo-radiopharmaceuticals/
- Published: 2020-11-11T12:00:00.000Z
- Updated: 2026-09-14T16:36:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148063

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Regulations for *In Vivo* Radiopharmaceuticals Used for Diagnosis and Monitoring — 21 CFR Part 315” (OMB Control Number 0910–0409). The collection supports agency regulations in 21 CFR part 315 that require manufacturers of diagnostic radiopharmaceuticals to submit information that demonstrates the safety and effectiveness of: (**1**) A new diagnostic radiopharmaceutical; or (**2**) a new indication for use of an approved diagnostic radiopharmaceutical. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-12/pdf/2020-25023.pdf?ref=fdaweb.com).